Prednisone for Arthritis: Side Effects and Long-Term Risks
SavePrednisone reduces arthritis inflammation quickly but carries significant risks with regular or long-term use: bone thinning, elevated blood sugar, weight gain, immune suppression, and adrenal suppression. Rheumatologists aim to minimize steroid doses and transition to DMARDs or biologics to protect long-term health.
Last updated: July 2026History
Why is prednisone used for arthritis?
Corticosteroids like prednisone powerfully suppress inflammation. In conditions such as rheumatoid arthritis, polymyalgia rheumatica, lupus, and inflammatory muscle diseases, they rapidly reduce pain, swelling, and systemic symptoms 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy.
They are used in several ways: - Short bursts: To manage flares while waiting for disease-modifying drugs to take effect - Low-dose long-term: In some conditions like polymyalgia rheumatica, a maintenance course lasting months to years is required - Bridge therapy: To control symptoms until a slower-acting DMARD becomes effective
The goal in rheumatology is always to use the lowest effective dose for the shortest necessary duration, then taper 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy2Ref 2Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. (2023).2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2022 ACR guideline on glucocorticoid-induced osteoporosis: bone-protective recommendations (calcium, vitamin D, bisphosphonates) for patients on GC ≥2.5 mg/day for > 3 months.
What are the common short-term side effects?
Even short courses of prednisone produce recognizable effects 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy: - Elevated blood sugar: Prednisone raises blood glucose; this is particularly significant for people with diabetes or prediabetes, who may need medication adjustments. - Fluid retention: The face and ankles may swell; blood pressure can rise. - Insomnia and mood changes: Many people feel more energized or restless; irritability and mood swings are common. - Increased appetite: Often quite pronounced, contributing to weight gain. - Gastrointestinal discomfort: Taking prednisone with food reduces stomach irritation.
What are the risks with long-term prednisone use?
Longer use — weeks to months — adds significant risk 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy2Ref 2Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. (2023).2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2022 ACR guideline on glucocorticoid-induced osteoporosis: bone-protective recommendations (calcium, vitamin D, bisphosphonates) for patients on GC ≥2.5 mg/day for > 3 months3Ref 3Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019).Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline.Endocrine Society guideline on osteoporosis pharmacological management: bone-protective strategies including bisphosphonates for patients at fracture risk, including GC-induced:
Bone loss (glucocorticoid-induced osteoporosis) One of the most important long-term risks. Prednisone impairs calcium absorption and bone formation; fracture risk increases even at relatively low doses with prolonged use. Patients on long-term steroids are typically advised to take calcium and vitamin D, and may need bone density testing and a bisphosphonate medication 2Ref 2Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. (2023).2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2022 ACR guideline on glucocorticoid-induced osteoporosis: bone-protective recommendations (calcium, vitamin D, bisphosphonates) for patients on GC ≥2.5 mg/day for > 3 months.
Adrenal suppression Long-term steroid use suppresses the body's own cortisol production. Stopping prednisone abruptly after extended use can cause adrenal insufficiency — a potentially serious condition. Doses must be tapered gradually 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy.
Immune suppression and infection risk Corticosteroids reduce immune function, increasing susceptibility to infections including unusual ones. Patients on long-term steroids should be current on vaccines and report fevers promptly.
Cardiovascular effects Long-term use can raise blood pressure, affect cholesterol, and increase cardiovascular risk — already elevated in inflammatory arthritis patients 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy.
Metabolic effects (Cushing's features) Central weight gain, facial rounding, stretch marks, and muscle weakness can develop with prolonged high-dose use.
Cataracts and glaucoma Long-term use increases risk of posterior subcapsular cataracts and can raise intraocular pressure, warranting periodic eye monitoring 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy.
How is long-term steroid use managed safely?
Rheumatologists use several strategies to minimize harm 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy2Ref 2Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. (2023).2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2022 ACR guideline on glucocorticoid-induced osteoporosis: bone-protective recommendations (calcium, vitamin D, bisphosphonates) for patients on GC ≥2.5 mg/day for > 3 months:
- Use the lowest effective dose and taper toward the minimum needed for disease control
- Bone protection: Calcium, vitamin D, and often a bisphosphonate for patients at higher fracture risk — recommended by the 2022 ACR GIOP guideline for patients on glucocorticoids ≥2.5 mg/day for more than three months 2Ref 2Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. (2023).2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.2022 ACR guideline on glucocorticoid-induced osteoporosis: bone-protective recommendations (calcium, vitamin D, bisphosphonates) for patients on GC ≥2.5 mg/day for > 3 months
- Blood sugar monitoring — especially in people with diabetes or prediabetes
- Blood pressure monitoring
- Vaccination review before starting long-term steroids
- Never stop abruptly — always taper under clinician guidance after extended use
What are the alternatives to long-term prednisone?
For rheumatoid arthritis, conventional DMARDs (methotrexate, hydroxychloroquine, sulfasalazine) and biologic therapies (TNF inhibitors, JAK inhibitors, and others) do not carry the same long-term risks as steroids 1Ref 1Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021).2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy3Ref 3Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019).Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline.Endocrine Society guideline on osteoporosis pharmacological management: bone-protective strategies including bisphosphonates for patients at fracture risk, including GC-induced. These take weeks to months to reach full effect, which is why steroids are often used as bridge therapy. Modern RA management emphasizes reducing or eliminating steroids once DMARD therapy achieves disease control.
Common questions
Related
Joints & autoimmune
Methotrexate for Rheumatoid Arthritis: Side Effects GuideJoints & autoimmune
Can Rheumatoid Arthritis Be Cured? RA Remission ExplainedJoints & autoimmune
Rheumatoid Arthritis vs Osteoarthritis: Key Differences
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
Important safety considerations for prednisone
- —Fever or signs of infection while on prednisone — immune suppression means infections can be serious; contact your clinician
- —Stopping prednisone suddenly after weeks or months of use — risk of adrenal crisis; always taper under clinician guidance
- —Blood sugar levels significantly elevated — especially important for people with diabetes
- —Sudden fracture with minor trauma — may indicate steroid-induced bone thinning
This article provides general health education about corticosteroid therapy. Do not change your prednisone dose or stop it abruptly without guidance from your prescribing clinician. Gale does not prescribe medications.
Did this answer your question?
References
- 1.Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, et al. (2021). 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis & Rheumatology. doi:10.1002/art.41752 ✓ACR RA guideline: glucocorticoid use, bridge therapy principles, cardiovascular risk in inflammatory arthritis, and the goal of minimizing steroid exposure with DMARD therapy
- 2.Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. (2023). 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis & Rheumatology. doi:10.1002/art.42646 ✓2022 ACR guideline on glucocorticoid-induced osteoporosis: bone-protective recommendations (calcium, vitamin D, bisphosphonates) for patients on GC ≥2.5 mg/day for > 3 months
- 3.Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019). Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-00221 ✓Endocrine Society guideline on osteoporosis pharmacological management: bone-protective strategies including bisphosphonates for patients at fracture risk, including GC-induced
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy